This metabolite contains a PDE selectivity profile just like sildenafil and an in vitro potency for PDE5 about 50% of your parent drug. Plasma concentrations of the metabolite are about 40% of These noticed for sildenafil, so that the metabolite accounts for around 20% of sildenafil's pharmacologic consequences.Expenses of prescription medicines co